In this study we used chloroquine to characterize the internalization and lysosomal degradation of receptorbound 125 l-insulin by rat adipocytes and to determine the role of lysosomal processing of insulin in the shortterm biologic effects of the hormone. Chloroquine inhibited the degradation of 125 l-insulin bound to adipocytes by both association and dissociation experiments. In the former experiments, chloroquine caused a time-and concentration-dependent increase in specifically bound insulin owing to an increase in intact insulin and a decrease in degradation products, as determined by trichloroacetic acid precipitability and gel chromatographic analysis of material extracted from the cells. In the dissociation experiments, 50 fiM chloroquine decreased the rate of degradation by two thirds, as reflected in the release of degradation products from the cells. Chloroquine had no effect on the amount of 125 Mnsulin specifically bound to or degraded by isolated plasma membranes, on the degradation of 125 l-insulin by proteases in the incubation medium, or on the endocytotic uptake of receptorbound insulin. Quantitative electron microscopy, using monomeric ferritin-insulin, showed 50 juM chloroquine doubled the number of lysosomal structures containing ferritin. These findings are consistent with an inhibition by chloroquine of lysosomal degradation of internalized receptor-bound insulin. Chloroquine, at these same concentrations, had no effect on the ability of insulin to stimulate glucose transport and oxidation or to inhibit epinephrine-stimulated lipolysis. In these studies, we show that lysosomal degradation of internalized receptor-bound insulin is not necessary for insulin to cause short-term biologic effects in the adipocyte. DIABETES 29:475-486, June 1980.
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SUMMARY
In this study we used chloroquine to characterize the internalization and lysosomal degradation of receptorbound 125 l-insulin by rat adipocytes and to determine the role of lysosomal processing of insulin in the shortterm biologic effects of the hormone. Chloroquine inhibited the degradation of 125 l-insulin bound to adipocytes by both association and dissociation experiments. In the former experiments, chloroquine caused a time-and concentration-dependent increase in specifically bound insulin owing to an increase in intact insulin and a decrease in degradation products, as determined by trichloroacetic acid precipitability and gel chromatographic analysis of material extracted from the cells. In the dissociation experiments, 50 fiM chloroquine decreased the rate of degradation by two thirds, as reflected in the release of degradation products from the cells. Chloroquine had no effect on the amount of 125 Mnsulin specifically bound to or degraded by isolated plasma membranes, on the degradation of 125 l-insulin by proteases in the incubation medium, or on the endocytotic uptake of receptorbound insulin. Quantitative electron microscopy, using monomeric ferritin-insulin, showed 50 juM chloroquine doubled the number of lysosomal structures containing ferritin. These findings are consistent with an inhibition by chloroquine of lysosomal degradation of internalized receptor-bound insulin. Chloroquine, at these same concentrations, had no effect on the ability of insulin to stimulate glucose transport and oxidation or to inhibit epinephrine-stimulated lipolysis. In these studies, we show that lysosomal degradation of internalized receptor-bound insulin is not necessary for insulin to cause short-term biologic effects in the adipocyte. DIABETES 29:475-486, June 1980. E xtensive investigation has established that the biologic responses to insulin are initiated by the binding of the hormone to receptors on the plasma membrane of target cells. 1 Terris and Steiner 2 ' 3 first showed that a portion of receptor-bound insulin was degraded by hepatocytes and suggested that degradation followed internalization and localization to lysosomes. It is now accepted that a portion of bound insulin is internalized by hepatocytes and fibroblasts through receptor-mediated endocytosis. 4 " 9 Internalized insulin preferentially localizes to lysosomes in the hepatocyte. 10 " 12 Several investigators have shown that bound insulin is degraded by the adipocyte 13 -16 and in several studies have demonstrated compartmentalization and, thus, possible internalization of bound insulin by the cell. 14 ' 16 "" 18 The plasma membranes of both hepatocytes 19 ' 20 and adipocytes 15 contain insulin-degradative activity, and Dial et ai. 20 have shown bound insulin to be an efficient substrate for degradation by mouse liver membranes. This membrane degradation must account for some of the degradation of bound insulin by intact cells. The destination and fate of insulin internalized by the adipocyte has not been established nor has the function of internalization been determined. It has been suggested that internalization of bound insulin and possibly its degradation at the plasma membrane or within the cell may be important in the mechanism by which insulin eiicits its characteristic biologic effects in its target cells, 2 ' 3i10i13i18>21 or, the mechanism by which downregulation of the insulin receptor occurs. 10 - 22 In this work we employed both biochemical and morphologic techniques using chloroquine, an inhibitor of lysosomal degradation of macromolecules 23 " 25 that include low-density lipoprotein 26 and epidermal growth factor, 27 to study the internalization and lysosomal degradation of receptor-bound 125 l-insulin by isolated adipocytes and to determine if lysosomal degradation of insulin participates in the short-term biologic effects of the hormone.
I from New England Nuclear and Amersham, Arlington Heights, IL; glass fiber GF/C filters from Whatman, Ltd., England; epinephrine HCI from ParkeDavis, Detroit, Ml; Enzymobead Radioiodination Kit (catalog no. 170-6002) from Bio-Rad Laboratories, Richmond, CA. Other reagents and chemicals were from standard sources.
METHODS
Preparation of 125
l-insulin. lodination of insulin was carried out by either a chloramine-T 28 or a lactoperoxidase method 29 using the Enzymobead Radioiodination Kit 30 to a specific activity of 120-180 /xCi//xg and was purified over a Sephadex G-50 column. The resulting 125 l-insulin contained an average of less than 0. 5 I-BSA. lodination of BSA* was carried out by the same chloramine-T method used for iodination of insulin, except BSA was substituted for insulin on a molar basis. The iodinated material eluting just after the void volume of a G-50 Sephadex column was taken to be 125 I-BSA. Preparation of isolated adipocytes. Adipocytes were isolated from epididymal fat pads of male Sprague-Dawley rats, weighing 120-180 g, by a modification 32 of the method of Rodbell 33 using 0.5 mg/ml collagenase in KRP-AG or KRH-AG buffer. KRH buffer contained 125 mM NaCI, 5.9 mM KCI, 2.5 mM CaCI 2 , 1.25 mM MgSO 4 , 2.5 mM NaH 2 PO 4 , and 20 mM Hepes. KRP buffer contained 128 mM NaCI, 5.1 mM KCI, 1.4 mM CaCI 2 , 1.4 mM MgSO 4 , and 10 mM NaH 2 PO 4 . The pH of each buffer was adjusted to 7.4 with NaOH. Preparation of adipocyte plasma membranes. Isolated plasma membranes were prepared by the method of Jarett 34 with minor modifications. 35 The membranes were resuspended in KRP buffer and the protein content was determined by the method of Lowry.
36
Determination of cell-associated label. Recent evidence has shown that bound 125 l-insulin in adipocytes consists not only of intact insulin but also of higher and lower molecular weight compounds. 6i10J3J4 ' 16 Thus, the term cell-associated label more aptly describes this spectrum of labeled compounds and will be used occasionally in this report. Use of " The abbreviations used are TC, trichloroacetic acid; BSA, bovine serum albumin (fraction V); Hepes, 4-(2-hydroxyethyl)- the term bound insulin will also connote cell-associated label and will not imply that the radioactivity measured represents only intact insulin. Cell-associated label or 125 l-insulin binding was measured by the microfuge separation method of Gammeltoft and Gliemann, 37 substituting silicone oil for dinonyl phthalate or diluting with cold buffer and centrifuging through silicone oil, as described by Gliemann and Sonne.
13 125 l-labeled insulin binding and degradation. All binding studies with cells were performed at 37°, except as noted in KRH-AG buffer at pH 7.4. The final concentration of cells was 10 5 -10 6 /ml. Cells were preincubated for 10 min with or without chloroquine or ammonium chloride, and 125 Iinsulin was then added to a final concentration of 330 pM. Cell-associated label was determined at prescribed intervals. Nonspecific binding was the amount of 125 l-insulin bound in parallel incubations, to which unlabeled insulin, at a final concentration of 8.0 fxM, was added simultaneously with the 125 l-insulin. The degradation of insulin was followed by measuring the TC precipitability of the label in the incubation medium. This technique with adipocytes parallels two more sensitive measures of insulin degradation-immunoprecipitability and rebinding to membranes. 15 A 50-/xl aliquot was taken from the infranatant of each microfuge tube used to measure cell-associated 125 l-insulin, and precipitability of the aliquot with 10% TC was determined. When the effects of potassium azide or potassium cyanide on 125 l-insulin binding and degradation were being measured, these agents were added at the beginning of the preincubation. l-insulin binding to adipocyte plasma membranes. Suspensions of plasma membranes, at a final concentration of 600-900 (JLQ protein/ml, were incubated at 37° in KRP with 1% BSA, pH 7.4, in the presence or absence of chloroquine. After 30 min, 125 l-insulin was added for a final concentration of 330 pM and the incubation was continued for 40 min. Each incubation was terminated by layering 100 /xl of the incubation suspension over 250 /xl of ice cold 0.25 M sucrose in KRP in a 400-/xl microfuge tube and centrifuging 1 min at 10,000 g. The tips of the microfuge tubes containing the membrane pellets were cut off and counted to determine membrane-associated radioactivity. Specific binding of 125 l-insulin to plasma membranes was determined by subtracting from total binding the amount of nonspecifically bound label in parallel triplicate incubations to which 8.0/xM unlabeled insulin was added simultaneously with the 125 Iinsulin. As with cells, degradation of 125 l-insulin was followed by measuring TC precipitability of a 50-/xl aliquot of supernatant. Extraction and analysis of cell-bound 125 l-insulin. Adipocytes were incubated with labeled insulin and chloroquine and were separated from incubation medium by centrifugation through silicone oil, as described for binding studies. The cells were then immediately extracted with 4M urea, 1M acetic acid, and 0.1% Triton X-100, and the recovery of cellassociated counts was more than 90%. Aliquots of the extracts were analyzed by precipitation in 10% TCorgel chromatography using Sephadex G-50. The column (0.9 x 55 cm) was equilibrated and eluted at room temperature with 1M acetic acid containing 0.9% NaCI.
Dissociation of bound 125
l-insulin and analysis of bound and released labeled material. Adipocytes were incubated at 37° for 10 min in the presence or absence of chloro-quine; 670 pM 125 l-insulin was added and the incubation was continued for 45 min. Cells were centrifuged and the infranatant was aspirated. The cells were then washed twice in incubation buffer and resuspended in fresh incubation buffer at 37° containing 8.0 /xM unlabeled insulin. Each set of cells was washed and resuspended in buffer that contained the same concentration of chloroquine as was in the initial incubation. At intervals during dissociation, aliquots of the incubation were analyzed by microfuge separation through silicone oil. The cell layer above the oil was immediately extracted with urea, acetic acid, and Triton X-100, was counted, and aliquots were analyzed by TC precipitation and gel column chromatography, as described above, to determine the amount and nature of labeled material remaining with the cells at each time point. A 50-/u,l aliquot of the infranatant from each microfuge tube was quickly added to 200 /xl of the extraction mixture and was subsequently analyzed by TC precipitation to determine the nature of labeled material released from the cells during dissociation. ]sucrose with cells was carried out in the same manner, except that the amount of trapped labeled sucrose was also measured. Cells were incubated at 37° with or without chloroquine for 10 min, labeled sucrose was then added to the incubations, and cell-associated labeled sucrose was determined at selected times during the incubation. Cell-associated [ 14 C]sucrose measured immediately after addition of the labeled sugar was taken to represent label trapped in extracellular water. This value for the trapped labeled sucrose was subtracted from cell-associated label at each later time point to determine the amount of label accumulated by cells during the incubation. Morphologic studies on adipocytes using ferritin-insulin. Isolated adipocytes were incubated with monomeric ferritin-insulin at 37° for 45 min in the presence and absence of 50 (xM chloroquine. The monomeric ferritin-insulin was the same preparation used in previous studies. 38 After incubation the cells were washed and processed for electron microscopy, as previously described. 39 This experiment was repeated twice, and electron mcrographs of more than 100 lysosomal structures in randomly selected cells were obtained for each experimental condition. The micrographs were analyzed for the presence of ferritin in each lysosomal structure without knowledge of the experimental conditions. Lysosomal structures included multivesicular bodies as well as dense bodies, as defined by others.
10
Assays of glucose oxidation, 3-O-methylglucose transport, and epinephrine-stimulated lipolysis in adipocytes. The effect of chloroquine on basal and insulin-stimulated glucose oxidation was determined by adding 5 x 10" cells to vials that contained various concentrations of chloroquine (from 0 to 100 ;u,M) in a final volume of 2 ml. After 15 min at 37°, 130 or 330 pM insulin was added to appropriate vials; the incubation was continued for 15 min, when D- [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]glucose (5.0 /AM) was added to all vials, which were immediately capped. After incubation for another 60 min at 37°, the 14 CO 2 released was determined as described by Gliemann. 40 The effect of chloroquine on basal and insulin-stimulated transport of 3-0-MG into adipocytes was measured using a rapid filtration assay described previously, 41 substituting KRH buffer for KRP and KRB. Cells were preincubated for 10 min at 37° in plastic tubes in the presence of chloroquine at concentrations of 0-100 (xM; then insulin (at 1.7 nM) was added to appropriate tubes and the incubation was continued for 40 min: 3-O-[methyl-
3 H]glucose (0.5 mM) was then added for a 15-s incubation, which was terminated by the addition of ice-cold 2 mM HgCI 2 . The cells were immediately collected by filtration, and the 3-O-[ 3 H]MG taken up by cells was determined as described. 41 The uptake of L-[1-14 C]glucose was simultaneously determined in each tube, and this value was used to correct for the nonspecific uptake of 3-O-[ The ability of insulin to inhibit epinephrine-stimulated lipolysis was measured in the presence and absence of chloroquine by a modification of a previously published procedure. 42 Adipocytes were incubated with chloroquine, at 0-100 /xM, for 10 min at 37° with or without 0.7 /xM epinephrine. Insulin, at 670 pM, was then added to appropriate tubes and the incubation was continued for 45 min. The reactions were terminated by the addition of 3M HCIO 4 and the mixture was centrifuged. Aliquots of each infranatant were neutralized with KHCO 3 and glycerol was determined on each aliquot by the method of Lowry et al. 43 
RESULTS
Effect of chloroquine and NH 4 CI on 12s
l-insulin binding to adipocytes and adipocyte-isolated membranes. Figure 1 is a demonstration of the effect of chloroquine on specific binding of 125 l-insulin by adipocytes. In the control preparations, specific binding reached a steady state level by 20 min of incubation, which was maintained for at least 2 h. Chloroquine caused a concentration-related increase in specifically bound insulin. In the presence of 5 fxM chloro- quine, the lowest concentration tested, specific binding was. 130% of control at 30 min of incubation and was twice the control's by 120 min. Increasing the concentration of chloroquine to 100 /JLM increased specific binding of insulin to 164% of control at 30 min of incubation and to more than triple the control value at 120 min. Chloroquine, at 20 /xM, caused intermediate effects. For each chloroquine concentration tested, the amount of specifically pound 125 l-insulin increased steadily with time of incubation and did not reach a plateau or steady state level, suggesting that chloroquine caused a time-dependent process of accumulation of specifically bound insulin in the adipocyte. Nonspecific binding of 1 "l-insulin was constant from 10 through 180 min of incubation and was not affected by chloroquine (data not shown).
NH4CI, like chloroquine, inhibits lysosomal degradation of macromolecules, including EGF in fibroblasts 27 and human chorionic gonadotropin in Leydig cells.
44i4S Specific binding of 330 pM 125 l-insulin to adipocytes incubated for 45 min at 37° was increased to 123% and 131% of control in the presence of NH 4 CI at 20 and 50 mM, respectively. Nonspecific binding was not affected.
Ghloroquine had no effect on degradative activity released into the incubation medium. Cells were incubated for 2 h in KRH-AG buffer at 37° in the absence of both chloroquine and insulin. The cells were then removed by centrifugation, leaving buffer containing degradative activity released from the cells. Aliquots of this buffer, containing released degradative activity, were incubated with various concentrations of chloroquine up to 2500 /u.M and 170-330 pM 125 l-insulin, and degradation of 125 l-insulin was followed by TC precipitability over 3 h. The amount of 12^l -insulin degraded to TC-soluble labeled material did not differ from control for any concentration of chloroquine tested at any time (data not shown).
The effect of chloroquine on plasma membrane binding and degradation of insulin was tested. Specific binding of 125 l-insulin to plasma membranes was determined after up to 40 min of incubation in the presence of chloroquine at concentrations of 0-250 fiM. In each experiment, chloroquine caused small increases or decreases in specific binding relative to control, and the total pattern over four experiments was that chloroquine had no effect on specific binding of 125 |-insulin to plasma membranes. Chloroquine also did not affect either nonspecific binding or degradation of 125 l-insulin by adipocyte plasma membranes (data not shown).
Degradation of 125 l-insulin by suspensions of adipocytes can occur in the incubation medium, at the plasma membrane, or within the cell after internalization. The combined effects of these degradative processes were determined by measuring the amount of TC-soluble labeled material in the incubation medium in the experiments shown in Figure 1 . A progressive decrease in the TC-soluble material was found in the incubation medium from cells treated with increasing concentrations of chloroquine ( Table 1 ). The decrease was significantly different statistically from control in the 20 /u.M and 100 fxM chloroquine conditions. Similar small, but statistically significant, decreases in the amount of TC-soluble labeled material present in the incubation medium after incubations of several hours were seen in other similar experiments. Since chloroquine did not alter the degradative ac- Data are from the same experiment shown in Figure 1 . After 180 min of incubation, cells were removed as described in METHODS. Aliquots of incubation medium were precipitated with 10% TC, and the soluble counts in the supernatant were quantitated and expressed as the percent of total counts present at the start of the incubation to derive a measure of Sucrose is taken into cells from the extracellular medium by nonspecific fluid phase endocytosis, enters the lysosome, and accumulates there without being degraded until residual lysosomal contents are expelled from the cell. 46 In Table 2 , we show that the amount of [ 14 C]sucrose accumulated by chloroquinetreated cells was not significantly different statistically from controls at any concentration tested, but the data suggest there is a small concentration-dependent stimulation by chloroquine. The magnitude of this increase was small com- (14) 116 ± 11 (9) 129 ± 11 (14) Adipocytes were incubated at 37° with [
14 C] sucrose in the presence of the indicated concentrations of chloroquine, and the amount of [ 14 C] sucrose accumulated over 60 min was determined as described in METHODS. The experiment was performed three times. Within each experiment, each experimental value was expressed as the percent of the mean of control values for that experiment, allowing data from all three experiments to be compared statistically. The values in this table represent the mean and SEM for each set of data, with the number of observations in parentheses. None of the experimental values was statistically significant compared with control (P > 0.05) by the unpaired / test. pared with the increase in specific binding of 125 l-insulin at 60 IT 'n in the presence of these concentrations of chloroquii: - (Figure 1 ), and it cannot explain the effect of chloroquit.f on specific binding of 125 l-insulin to adipocytes. Similar experiments showed that concentrations of chloroquine of up to 1000 JU,M had no significant effect on the amount of 125 l-albumin associated with the cells at incubations of up to 120 min (data not shown). The lack of any effect of chloroquine on nonspecific binding of 125 l-insulin in repeated experiments was the most direct evidence against the stimulation of nonspecific uptake of insulin by chloroquine. Effect of lowered temperature and inhibitors of energy generation on the action of chloroquine. If chloroquine inhibits processing of internalized 125 l-insulin at the level of the lysosome, then preventing the internalization of 125 l-insulin should prevent the accumulation of cell-bound 125 l-insulin seen in the presence of chloroquine. This was tested through two approaches, designed to block internalization by inhibiting energy-requiring endocytosis of receptorbound 125 l-insulin. The effect of lowering the incubation temperature is shown in Table 3 . At 37°, 20 /xM chloroquine caused a 242% increase in specific binding at 180 min of incubation. At 24°, this same chloroquine concentration stimulated specific binding by only 53% at 210 min, and it had no effect at 14°. It should be noted that specific binding to control cells increased as the temperature decreased. The requirement of an energy-dependent uptake system for internalization of specifically bound 125 l-insulin before the site of the chloroquine effect was further tested by the use of potassium cyanide and sodium azide, metabolic inhibitors that deplete adenosine triphosphate (ATP) in the adipocyte. 17 ' 47 Neither of these agents had a significant effect on specific or nonspecific insulin binding in the absence of chloroquine (data not shown). However, both agents caused a concentration-related inhibition of the increase in specific binding of labeled insulin caused by 50 /xM chloroquine. In the absence of inhibitors, 50 /xM chloroquine caused a 107% increase over control in specific binding of 330 pM 125 l-insulin after 45 min of incubation. In the presence of 5 mM potassium azide or 5 mM potassium cyanide, 50 fiM chloroquine stimulated specific binding by only 23% and Cells were incubated with or without 20 /u.M chloroquine for 10 min at 37°, then quickly cooled to final incubation temperature.
125 Iinsulin, at 330 pM, was added and the incubation was continued for 180 min (14° and 37°) or 210 min (24°); specific binding was determined as in METHODS. Nonspecific binding was not affected by chloroquine at any temperature and did not vary significantly with temperature. These data are representative of two or more experiments at each temperature. Each value represents x ± SEM of quadruplicate samples. Adipocytes were incubated with 330 pM 12s l-insulin for 45 min at 37°C in the absence or presence of chloroquine. Cells were separated from incubation medium, extracted, and analyzed as described in METHODS. This is a representative experiment from a set of three. Each value of TC-precipitable and TC-soluble counts is represented as x ± SEM of quadruplicate samples and as percent of total bound at that chloroquine concentration. 40%, respectively. These results are consistent with a site of chloroquine action distal to an energy-requiring internalization step, such as receptor-mediated endocytosis. Nature of cell-associated insulin. The effect of chloroquine on the nature of cell-associated ' 2S l-insulin was determined by TC precipitation and by gel chromatography of extracted cell-bound label. In Table 4 , we demonstrate the effect of chloroquine, at 20-100 /xM, on the TC precipitability of labeled material extracted from cells incubated for 45 min with 330 pM 125 l-insulin. As seen previously (Figure 1 ), increasing chloroquine concentrations caused a progressive increase in total cell-bound iodinated insulin. The TC-precipitable material accounted for this increase in total binding, so that at the highest chloroquine concentrations the TC-precipitable label was a greater percent of the total bound, suggesting a build-up of intact insulin and an inhibition of degradation. Degraded 125 l-insulin is rapidly expelled from the cell, The effect of chloroquine on cell-associated insulin was examined further by gel filtration analysis of the cell-extracted material. Figures 2A, B , and C illustrate the effect of 20, 50, and 100 /xM chloroquine, respectively, on the composition of bound labeled material at 45 min of incubation. Consistent with the changes seen in TC precipitability of bound labeled material, increasing chloroquine concentrations caused a progressive increase in extracted material eluting with intact insulin and a corresponding decrease in low molecular weight degradation products. The number of counts eluting in the 125 l-insulin peak was 163%, 179%, and 184% of control for cells incubated with 20, 50, and 100/xM chloroquine, respectively. The sum of counts eluting in the peaks succeeding the 125 l-insulin peak, which represent degradation products, fell to 77%, 77%, and 57% of control as chloroquine was increased to 20, 50, and 100 fxM, respectively. The number of counts eluting before the insulin peak did not show consistent changes with chloroquine. Morphologic studies on the effects of chloroquine on the lysosomal content of ferritin-insulin. In recent elec- tron-autoradiographic studies using 125 l-insulin, internalized insulin associated specifically with the lysosome of the hepatocyte. 10 In morphologic studies of the adipocyte using ferritin-insulin, the hormone specifically localized to the glycocalyx coating of the plasma membrane and in the numerous surface invaginations and related microvesicles. 39 Lysosomal structures were rarely seen nor were looked for in those studies. In our experiments here, we photographed lysosomes in adipocytes incubated with monomeric ferritininsulin in the presence or absence of 50 /xM chloroquine for 45 min. Figure 3 is an electron micrograph of a chloroquinetreated cell showing a lysosomal structure (heterophagosome or multivesicular body). Structures resembling endocytotic vesicles are seen inside this organelle as well as numerous ferritin-insulin particles associated with the vesicles or with glycocalyx-like amorphous material. By quantitative analysis, we showed that, while only 35% of the lysosomal structures from control cells contained ferritin, 68% of them from chloroquine-treated cells contained the particles (P < 0.01 by t test). Other electron micrographs showed microvesicles containing ferritin-insulin fusing with the lysosomal structures, indicating the route of entry of ferritin-insulin into the cell. These microvesicles were not coated nor were the invaginations that gave origin to the vesicles. This morphologic study supports the biochemical data, suggesting that chloroquine inhibits the degradation by lysosomes of internalized insulin and the hormone accumulates in the organelle. Effect of chloroquine on dissociation of bound '"l-insulin from adipocytes. Dissociation experiments were performed to further characterize the effect of chloroquine on the degradation of internalized 125 l-insulin. These experiments allowed us to determine the rate of degradation of cell-bound 125 l-insulin when extracellular degradation was absent and to analyze the nature of the labeled material both released from the cell and remaining with the cell during dissociation. Figure 4A shows the amount and the TC precipitability of the 125 l-insulin remaining in the cells during the course of dissociaton, after an original 45-min incubation in the presence and absence of 50 /xM chloroquine. The time required for dissociation of half the labeled insulin bound at the beginning of dissociation was definitely increased by chloroquine (8 min vs. 28 min). The dissociation was virtually complete for control cells by 120 min, and less than 10% remained with the cells at 60 min. In contrast, 37% and 26% of initial counts remained bound to chloroquine- 
LD
._jt_ . _ . treated cells at 60 and 120 min, respectively. Even at 180 min, 21% of initial counts remained bound to the chloroquine-treated cells. Other workers showed 2i10i13J4 that both intact and degraded labeled material dissociated from or was released by cells that had been allowed to bind 125 l-insulin, were washed and resuspended in fresh medium. We performed such experiments in the presence and absence of chloroquine. In Figures 4B and C (Table 4 and Figure 4A ), the rate of release of degradation products from cells into the medium during dissociation should reflect the rate of degradation of 125 l-insulin by the cells. The release of degraded material by control (B) and chloroquine-treated (C) adipocytes is also shown in Figure 4 . The most striking effect of chloroquine was the distinct reduction in the amount of TC-soluble material released by chloroquine-treated cells compared with that by control at the early time points. The amount of TC-soluble material dissociating from the chloroquinetreated cells was less than half that of the control at 30 s or 10 min. The rate of appearance of TC-soluble material over the first 10 min can be taken as an estimate of the initial rate of total cellular degradation of l-insulin specifically bound to chloroquine-treated cells at the beginning of the dissociation was approximately twice as much as the amount bound initially to control cells. If specifically bound insulin is the substrate for uptake and degradation, then the rate of degradation should be corrected for differences in initial binding by normalizing all data (using the initial counts bound as 100%) for each set of cells. Using this corrected or normalized data, the rate of degradation for chloroquine-treated cells over the first 10 min was only 20% of control.
The number of TC-precipitable counts which dissociated "from chloroquine-treated cells and controls was roughly equal at early time points. However, the release of TC-precipitable labeled material from control cells was almost completed at 10 min, while TC-precipitable material continued to dissociate from chloroquine-treated cells until at least 60 min. The amount of TC-precipitable labeled material which dissociated from chloroquine-treated and control cells was compared using normalized data, in which the number of initial counts bound was set at 100% for each set of cells. This showed that 49% of counts initially bound to control cells had dissociated as TC-precipitable material through 180 min. Illustrating the fact that dissociation of TC-precipitable material from control cells was nearly completed by 10 min, 44% and 47% of initial counts had dissociated as TC-precipitable material at 10 and 30 min, respectively. The dissociation of TC-precipitable counts from chloroquine-treated cells was essentially complete at 60 min, with 45% and 48% of initial counts being released at 60 and 180 min. The release of TC-precipitable counts was somewhat slowed by 50 fj.M chloroquine, with 30% and 39% of initial counts being dissociated at 10 and 30 min. The reduction in the rate of release of bound 125 l-insulin on TC-precipitable material was much smaller than the striking reduction in the rate of release of degraded 125 l-labeled material from chloroquine-treated cells.
The labeled material remaining with the cells during the dissociation process was predominantly TC precipitable for both chloroquine-treated and control cells (Figure 4 ). These cell extracts were further analyzed by gel filtration (data not shown). The amount of material eluting after the insulin peak, thus representing degraded material, was only a small portion of the total cell-associated counts at all times, confirming that degraded material exits rapidly from the cell. The size of the 125 l-insulin peak was much larger for chloroquine-treated cells than for control at the time dissociation began. The extremely small amount of material in the degradation product region for the chloroquine-treated cells explains why about 90% of the total cell-associated material during dissociation was TC precipitable. The amount of material in the degradation region for the control was equal to that for the chloroquine-treated cells, but the lower amount of intact insulin in control cells correlates with the lower TC precipitability of the total material extracted from control cells compared with chloroquine-treated cells. The rapid dissociation of bound 125 l-insulin from control cells was also analyzed by gel chromatography. At 30 min of dissociation, only a small amount of label remained with the cells, and this was accounted for almost entirely by counts eluting in the higher molecular weight peaks, suggesting the processing of 125 l-insulin to high molecular weight species as well as to low molecular weight degradation products. Essentially no counts remained with control cells after 60 (or 120) min of dissociation.
As expected, dissociation was much less rapid from chloroquine-treated cells, with a substantial amount of counts remaining in each set of peaks at 30 min. The number of counts in the insulin peak decreased to 41% of the initial amount, but the amount of high molecular weight material did not change. Even after 180 min of dissociation, a fourth of the counts initially bound remained with chloroquine-treated cells. Labeled material eluting before the 125 Iinsulin peak accounted for 58% of the total compared with 21% at 0 min. Counts eluting in the 125 l-insulin peak accounted for only 21% of the total at 180 min compared with 67% at 0 min, reflecting the relatively rapid rate of dissociation of intact 125 l-insulin. In other experiments, in which dissociation was carried beyond 3 h, residual bound counts were entirely accounted for by peaks preceding the insulin peak. For both chloroquine-treated and control cells, the last labeled material to dissociate was the high molecular weight species eluting before intact insulin. Effects of chloroquine on the stimulation of glucose oxidation by insulin. Insulin stimulates the oxidation of glucose to CO 2 by adipocytes by both increasing the transport of glucose into the cell and altering the activities of rate-limiting enzymes within the cell. 48 The effect of chloroquine on the stimulation of glucose oxidation by insulin was tested at two insulin concentrations, one a concentration causing maximal or near maximal stimulation of glucose oxidation (330 pM) and a submaximal concentration (130 pM). In Figure 5 , we demonstrate that chloroquine, at either 50 or 100 /xM, had no significant effect on insulin-stimulated glucose oxidation at either insulin concentration. Effect of chloroquine on the stimulation of 3-O-MG transport by insulin.. The effect of chloroquine on the ability of insulin to directly stimulate glucose transport, a membrane response, was more directly tested through the use of 3-0-MG, a nonmetabolizable glucose analogue that utilizes the same transport system as glucose. 49 In Figure 6 , we demonstrate the effect of chloroquine, at 0-100 /xM, on 3-O T [ 3 H]MG transport by adipocytes in the presence of 1.7 nM insulin. At the concentrations tested, chloroquine did not inhibit insulin-stimulated 3-0-MG transport. In addition, chloroquine did not effect the uptake of L- [1- 14 C]glucose in these experiments, a fact which provides evidence that chloroquine did not cause an increase in simple diffusion. Effect of chloroquine on the ability of insulin to inhibit epinephrine-stimulated lipolysis. In the experiments concerning glucose oxidation and 3-0-MG transport, we examined the effect of chloroquine primarily on an insulin-sensitive membrane response. The ability of insulin to block epinephrine-stimulated lipolysis was chosen as a way in which we could determine whether chloroquine had any effects on insulin-sensitive intracellular metabolic processes. Epinephrine stimulates lipolysis of stored triglyceride in the rat adipocyte through stimulation of the activity of hormonesensitive lipase, 50 and insulin inhibits this lipolytic effect of epinephrine. 51 In Figure 7 , we illustrate the effect of chloroquine on these processes. The stimulation of lipolysis by 0.7 juM epinephrine was not affected by chloroquine. Insulin, at 660 pM, reduced the rate of epinephrine-stimulated lipolysis by about 50%. Insulin's inhibition of the epinephrine effect was not influenced by chloroquine at any concentration tested.
•
DISCUSSION
In the present report, we employed both biochemical and morphologic techniques to investigate the process of uptake, degradation, and release of receptor-bound insulin by adipocytes, and, through the use of chloroquine, we established the role of the lysosome in the degradation of internalized insulin. The data reported are consistent with the following model. A portion of 125 l-insulin specifically bound to its surface receptor was internalized by the cell through an energy-dependent process involving noncoated invaginations and endocytotic microvesicles, i.e., receptor-mediated endocytosis.
8>1° Some or all of this internalized insulin became localized to lysosomal structures through fusion of the endocytotic microvesicles with the lysosomes. Degradation then occurred in the lysosome with rapid expulsion of the small molecular weight degradative products from the cell. These studies further showed that lysosomal degradation of internalized receptor-bound insulin was not necessary for insulin to cause its short-term biologic effects.
Chloroquine, an agent known to accumulate in lysosomes of fibroblasts and to inhibit degradation of macromolecules by the lysosome, caused an inhibition of degradation of specifically bound insulin by adipocytes and a resultant increase in specifically bound, labeled material, shown to be primarily intact insulin. The inhibition of insulin degradation was demonstrated directly and most convincingly by the dissociation studies. The decreased initial rate of appearance of TC-soluble degradation products in the incubation media of chloroquine-treated cells showed that chloroquine greatly decreased the rate of degradation of insulin by the adipocyte. The analysis of the 125 l-labeled material extracted from cells during the association phase provided additional evidence of decreased degradation. Analysis by both TC precipitation and gel filtration chromatography demonstrated that, in the presence of chloroquine, the increase in cell-associated insulin was accounted for by a large increase in the amount of intact insulin and the amount of degradation products present in the cell was less than that in controls. The small amounts of degradative products found in both control and chloroquine-treated cells reflected the rapid explusion of these low molecular weight products from the cell. The large increase in intact insulin found in chloroquine-treated cells is consistent with the concept that a rapid turnover of internalized material occurred in control cells, so that the inhibition of degradation by chloroquine caused intact insulin to build up in the cell. Finally, the finding that chloroquine resulted in a significantly lower amount of TC-soluble material in the incubation medium of chloroquine-treated cells compared with that in controls at the end of a 3-h incubation of adipocytes with labeled insulin provided further support for the conclusion that chloroquine inhibited insulin degradation. These experiments support the conclusion that the inhibition of degradation of specifically bound insulin by chloroquine was due to an inhibition of lysosomal processing of internalized insulin.
If chloroquine interfered with some step in the uptake of insulin by the adipocyte before degradation by the lysosome, then results similar to those reported here might be found. Experiments were performed to rule out this possibility. First, chloroquine did not alter the degradation of insulin by proteolytic activity present in the incubation medium. Second, stimulation of nonspecific endocytosis by chloroquine, if it occurs, did not explain the effect of chloroquine on specific binding of 125 l-insulin to cells. Third, experiments showed that inhibitors of generation of intracellular energy, which reduce the rate of receptor-mediated endocytosis, caused a decreased accumulation of specifically bound 125 l-insulin in the presence of chloroquine. This supports the hypothesis that the effect of chloroquine on processing of intracellular insulin occurred at a point distal to the endocytotic step, at the level of the lysosome. Fourth, chloroquine did not affect specific binding of 125 l-insulin to or degradation by plasma membranes. Finally, electron microscope studies showed that chloroquine did not interfere with the fusion of endocytotic microvesicles and lysosomes, since twice the number of lysosomes contained ferritin-insulin in the presence of chloroquine than in its absence. A second agent reported to inhibit lysosomal degradation in several cell types-NH 4 CI-also caused a concentrationdependent increase in specific binding of 125 l-insulin to adipocytes.
The electron microscope studies provided morphologic evidence concerning the route of uptake into the cell of specifically bound insulin and its localization to the lysosome. Ferritin-insulin was associated with the glycocalyx coating on the cell surface in noncoated surface invaginations and with microvesicles in the cytoplasmic matrix and in lysosomal structures. In addition, microvesicles containing ferritin-insulin were observed fusing with lysosomal structures, suggesting that insulin is internalized by the adipocyte through a system of noncoated endocytotic microvesicles with subsequent localization to the lysosomes. These observations demonstrate morphologically the receptor-mediated endocytotic process suggested by the biochemical data. These morphologic observations are similar to those reported for EGF uptake by human carcinoma cells A-431. 52 Despite intensive searching for coated pits on the adipocyte surface, they were rarely found and showed no preferential localization of ferritin-insulin. The lack of participation of coated pits and coated vesicles in the uptake of ferritin-insulin into the adipocyte is consistent with recent observations by Carpentier et al., 10 who were unable to demonstrate any association of bound 125 l-insulin with coated pits of hepatocytes. Haigler et al. 52 found EGF was taken up by invaginations and microvesicles that were predominantly not coated, as well. Finally, the finding that chloroquine doubled the fraction of lysosomes containing ferritin-insulin was consistent with the biochemical data, suggesting that chloroquine's main site of action was at the lysosomal level. These morphologic data would support the theory that the intact insulin was accumulating in the lysosome in the presenceof chloroquine.
The ability of chloroquine to increase the specific binding of 125 l-insulin at reduced incubation temperatures was investigated to demonstrate that lowered temperature would reduce the rate of endocytosis and, thus, prevent the chloroquine effect. The difference in bound 125 l-insulin between chloroquine-treated and control cells was reduced or eliminated at lower temperatures, but not in the same manner as by inhibitors of intracellular energy generation. These inhibitors did not affect the amount of binding to control cells but did reduce the binding to chloroquine-treated cells, whereas lowering the temperature increased the level of cell-associated label in control cells to that seen in chloroquine-treated cells. This suggests that, at lowered temperature, control cells may function like chloroquine-treated cells. Thus, lowered incubation temperature may have inhibited lysosomal degradation to a greater extent than it inhibited receptor-mediated endocytosis with a resulting increase in cell-associated 125 l-insulin. Preliminary morphologic experiments showed that more lysosomal struc-tures contained ferritin-insulin at 15° than at 37° (L. Jarett and R. M. Smith, unpublished observations), consistent with this interpretation.
Gel chromatodVaphy of labeled material extracted from cells under all conditions tested revealed the presence of large molecular weight material eluting with or just after the void volume. The amount or composition of high molecular weight material extracted from cells incubated with 125 l-insulin did not vary in a consistent way with increasing concentrations of chloroquine (Figure 2) . Chromatographic analysis of labeled material remaining with cells during the dissociation experiments showed that the void volume material dissociated more slowly from the cell than did either intact 125 Mnsulin or degradation products, in both the presence and absence of chloroquine. Labeled material retained by chloroquine-treated cells after 4 h of dissociation was accounted for entirely by counts eluting before the 125 Iinsulin peak. Other investigators 18>53 strongly supports the conclusion that, in two important target cells for insulin-hepatocytes and adipocytes-a portion of receptor-bound insulin enters the cell by receptor-mediated endocytosis through noncoated surface invaginations and vesicles, localizes to lysosomes, and is degraded and released from the cell. Internalization and lysosomal processing of bound insulin could serve one or more general physiologic functions. 6 ' 8 Internalization and lysosomal processing could (1) enable the hormone or a piece of it to elicit a biologic response and, thereby, function, at least in part, as its own second messenger, (2) allow degradation of insulin and, thereby, possibly control the immediate duration of response to the ligand, or (3) control the number of receptors for the hormone, so as to maintain a homeostatic balance under chronic or large changes in circulating levels of the hormone.
Data from this study demonstrated that internalization and lysosomal processing of receptor-bound insulin is not a necessary step in the mechanism by which insulin elicits several short term biologic responses. Under conditions in which chloroquine progressively inhibited insulin degradation by the lysosome, the agent had no effect on insulin's alteration of glucose transport, glucose oxidation, or epinephrine-stimulated lipolysis. Other studies support this conclusion. Insulin, concanavalin A, and antireceptor antibody, added directly to a plasma membrane-mitochondria mixture, were reported to cause a specific plasma membrane-mediated stimulation of pyruvate dehydrogenase activity of isolated mitochondria, suggesting the generation of insulin's second messenger by this subcellular system without the need for internalization and lysosomal processing. 54 " 56 LeCam et al. 57 report that internalization of bound insulin by hepatocytes is not necessary for insulin to stimulate transport of a-amino isobutyric acid. Kono et al. 18 recently reported that insulin's stimulation of glucose transport in adipocytes is not blocked by chloroquine. Ascoli and Puett 44 ' 45 studied the effect of several lysosbmotropic agents on the stimulation of steroidogenesis in Leydig cells by human chorionic gonadotropin. They found that chloroquine did not prevent stimulation by the hormone. The possible importance of internalization and lysosomal degradation of bound insulin for longer term responses by the cell, such as increased DNA synthesis, remains unknown. Gliemann 13 suggested that degradation at the membrane of receptorbound insulin may be a fundamental step in the mechanism of insulin's action in the cell. The role of plasma membrane degradation has not been extensively investigated. However, with the development of an adipocyte plasma membrane preparation which demonstrates a biologic response to the direct addition of insulin, 54 " 56 the role of degradation at the plasma membrane in the mechanism of action of insulin can be investigated.
